Aclaris Therapeutics, Inc. Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aclaris Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aclaris Therapeutics, Inc. for February 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 10,800 | 0 | 32,400 | |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 6.96 | 3,579 | 24,910 | 917,345 | 920.9 K to 917.3 K (-0.39 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 10,800 | 0 | 920,924 | 910.1 K to 920.9 K (+1.19 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Option Exercise | M | 0.00 | 3,400 | 0 | 10,200 | |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Payment of Exercise | F | 6.96 | 1,114 | 7,753 | 141,729 | 142.8 K to 141.7 K (-0.78 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Buy | M | 0.00 | 3,400 | 0 | 142,843 | 139.4 K to 142.8 K (+2.44 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Option Exercise | M | 0.00 | 3,875 | 0 | 11,625 | |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Payment of Exercise | F | 6.96 | 1,308 | 9,104 | 272,047 | 273.4 K to 272 K (-0.48 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Buy | M | 0.00 | 3,875 | 0 | 273,355 | 269.5 K to 273.4 K (+1.44 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,875 | 0 | 11,625 | |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 6.96 | 1,308 | 9,104 | 164,976 | 166.3 K to 165 K (-0.79 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 3,875 | 0 | 166,284 | 162.4 K to 166.3 K (+2.39 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Option Exercise | M | 0.00 | 3,875 | 0 | 11,625 | |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Payment of Exercise | F | 6.96 | 1,308 | 9,104 | 10,582 | 11.9 K to 10.6 K (-11.00 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Buy | M | 0.00 | 3,875 | 0 | 11,890 | 8 K to 11.9 K (+48.35 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 3,875 | 0 | 11,625 | |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 6.96 | 1,308 | 9,104 | 82,212 | 83.5 K to 82.2 K (-1.57 %) |
| Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 3,875 | 0 | 83,520 | 79.6 K to 83.5 K (+4.87 %) |